Articles with "graft host" as a keyword



Biomarker profile predicts clinical efficacy of extracorporeal photopheresis in steroid‐resistant acute and chronic graft‐vs‐host disease after allogenic hematopoietic stem cell transplant

Sign Up to like & get
recommendations!
Published in 2021 at "Journal of Clinical Apheresis"

DOI: 10.1002/jca.21918

Abstract: We conducted a multicenter interventional study to assess the efficacy of Therakos ECP to treat steroid‐resistant graft‐vs‐host disease (SRes‐GVHD) after allogeneic HSCT and to identify biomarkers of GVHD response. A total of 62 patients were… read more here.

Keywords: response; sres gvhd; graft host; steroid resistant ... See more keywords

Role of extracorporeal photopheresis in the management of children with graft‐vs‐host disease

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of Clinical Apheresis"

DOI: 10.1002/jca.22012

Abstract: Graft‐vs‐host disease (GVHD) is a frequent cause of morbidity and mortality in allogeneic stem cell transplants. Extracorporeal photopheresis (ECP) is one of the most accepted second‐line treatments, but technical issues of ECP in children might… read more here.

Keywords: extracorporeal photopheresis; host disease; graft host;

Acute Graft-vs-Host Disease After Liver Transplantation in a Patient Presenting With Neurogenic Symptoms as the Single Primary Manifestation: A Case Report.

Sign Up to like & get
recommendations!
Published in 2018 at "Transplantation proceedings"

DOI: 10.1016/j.transproceed.2018.05.013

Abstract: Acute graft-vs-host disease (aGVHD) is a rare but deadly complication after liver transplantation (LT). It occurs when donor immunocompetent cells transplanted with the liver allograft repopulate and recognize recipient antigens as foreign and mount an… read more here.

Keywords: manifestation; graft host; transplantation; neurogenic symptoms ... See more keywords

Extracellular vesicles as potential biomarkers of acute graft-vs-host disease

Sign Up to like & get
recommendations!
Published in 2018 at "Leukemia"

DOI: 10.1038/leu.2017.277

Abstract: Acute graft-vs-host disease (GVHD) is a serious complication after allografting. We carried out an exploratory study to investigate a potential correlation of surface antigens on extracellular vesicles (EVs) and acute GVHD. EVs were extracted from… read more here.

Keywords: extracellular vesicles; acute gvhd; graft host; host disease ... See more keywords

Neural xenografts contribute to long-term recovery in stroke via molecular graft-host crosstalk

Sign Up to like & get
recommendations!
Published in 2025 at "Nature Communications"

DOI: 10.1038/s41467-025-63725-3

Abstract: Stroke is a leading cause of disability and death due to the brain’s limited ability to regenerate damaged neural circuits. To date, stroke patients have only few therapeutic options and are often left with considerable… read more here.

Keywords: host; long term; graft host; graft ... See more keywords

Role of Vessel Microstructure in the Longevity of End-to-side Grafts.

Sign Up to like & get
recommendations!
Published in 2019 at "Journal of biomechanical engineering"

DOI: 10.1115/1.4043873

Abstract: Compliance mismatch between the graft and the host artery of an end-to-side (ETS) arterial bypass graft increases the intramural stress in the ETS graft-artery junction, and thus may compromise its long-term patency. The present study… read more here.

Keywords: graft; graft host; bypass graft; host artery ... See more keywords

Keratoscope-guided opening of graft-host junction to treat elevated astigmatism after deep anterior lamellar keratoplasty

Sign Up to like & get
recommendations!
Published in 2025 at "British Journal of Ophthalmology"

DOI: 10.1136/bjo-2025-327208

Abstract: Aims To describe a simple surgical technique consisting of opening the vertical graft-host junction (GHJ) to manage high astigmatism following deep anterior lamellar keratoplasty (DALK) and to report postoperative visual and topographic outcomes. Methods This… read more here.

Keywords: deep anterior; graft host; lamellar keratoplasty; astigmatism ... See more keywords

Prognostic Value of Blood Biomarkers in Steroid-Refractory/Dependent Acute Graft-vs-Host Disease: A REACH2 Analysis.

Sign Up to like & get
recommendations!
Published in 2023 at "Blood"

DOI: 10.1182/blood.2022018579

Abstract: Systemic steroids are the standard first-line treatment for acute graft-vs-host disease (aGVHD), but approximately 50% of patients become steroid refractory or dependent (SR/D). Ruxolitinib is the only FDA and EMA approved therapy for patients with… read more here.

Keywords: day; host disease; reach2; acute graft ... See more keywords

Chronic graft-vs-host disease: Current understanding of disease and treatment landscape.

Sign Up to like & get
recommendations!
Published in 2022 at "Journal of managed care & specialty pharmacy"

DOI: 10.18553/jmcp.2022.28.12-b.s1

Abstract: Chronic graft-vs-host disease (cGVHD) is a common complication and a major cause of morbidity and mortality following allogeneic hematopoietic cell transplantation. It is primarily characterized by chronic inflammation and fibrosis involving multiple organs. Firstline treatment… read more here.

Keywords: chronic graft; disease; host disease; treatment ... See more keywords
Photo from wikipedia

A Possible Reason to Induce Acute Graft-vs.-Host Disease After Hematopoietic Stem Cell Transplantation: Lack of Sirtuin-1 in CD4+ T Cells

Sign Up to like & get
recommendations!
Published in 2018 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2018.03078

Abstract: Sirtuin 1 (SIRT1) is a critical suppressor of T cell immunity. However, whether SIRT1 is involved in the progression of acute graft-vs.-host disease (aGVHD) has still remained unclear. PI3K/Akt/mTOR pathway is a crucial element involved… read more here.

Keywords: cd4 cells; graft host; activation; host disease ... See more keywords
Photo from wikipedia

Dendritic Cell Regulation of Graft-Vs.-Host Disease: Immunostimulation and Tolerance

Sign Up to like & get
recommendations!
Published in 2019 at "Frontiers in Immunology"

DOI: 10.3389/fimmu.2019.00093

Abstract: Graft-vs.-host disease (GVHD) remains a significant cause of morbidity and mortality after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Significant progresses have been made in defining the dichotomous role of dendritic cells (DCs) in the development… read more here.

Keywords: dcs; graft host; host; host disease ... See more keywords